BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27348972)

  • 1. Anti-tumor activity of benzylideneacetophenone derivatives via proteasomal inhibition in prostate cancer cells.
    Lee YH; Yun J; Jung JC; Oh S; Jung YS
    Pharmazie; 2016 May; 71(5):274-9. PubMed ID: 27348972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".
    Yang H; Shi G; Dou QP
    Mol Pharmacol; 2007 Feb; 71(2):426-37. PubMed ID: 17093135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotective effects of benzylideneacetophenone derivatives on excitotoxicity and inflammation via phosphorylated Janus tyrosine kinase 2/phosphorylated signal transducer and activator of transcription 3 and mitogen-activated protein K pathways.
    Jang S; Jung JC; Kim DH; Ryu JH; Lee Y; Jung M; Oh S
    J Pharmacol Exp Ther; 2009 Feb; 328(2):435-47. PubMed ID: 18984655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin elicits proteasomal dysfunctions develops apoptosis through mitochondrial abnormalities.
    Amanullah A; Mishra R; Upadhyay A; Reddy PP; Das R; Mishra A
    J Cell Physiol; 2018 Feb; 233(2):1685-1699. PubMed ID: 28681929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy.
    Rioux B; Pinon A; Gamond A; Martin F; Laurent A; Champavier Y; Barette C; Liagre B; Fagnère C; Sol V; Pouget C
    Eur J Med Chem; 2021 Oct; 222():113586. PubMed ID: 34116328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.
    Ivković BM; Nikolic K; Ilić BB; Žižak ŽS; Novaković RB; Čudina OA; Vladimirov SM
    Eur J Med Chem; 2013 May; 63():239-55. PubMed ID: 23501110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro.
    Deb Majumdar I; Devanabanda A; Fox B; Schwartzman J; Cong H; Porco JA; Weber HC
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):397-402. PubMed ID: 22120630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
    Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
    Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T
    Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
    Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
    Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
    Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
    Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
    Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors.
    Zhang J; Cao J; Xu L; Zhou Y; Liu T; Li J; Hu Y
    Bioorg Med Chem; 2014 Jun; 22(11):2955-65. PubMed ID: 24767818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
    Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
    Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-angiogenic and anti-tumor activity of synthetic phenylpropenone derivatives is mediated through the inhibition of receptor tyrosine kinases.
    Lee JS; Kang Y; Kim JT; Thapa D; Lee ES; Kim JA
    Eur J Pharmacol; 2012 Feb; 677(1-3):22-30. PubMed ID: 22200628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of imidazothiazole-chalcone derivatives as anticancer and apoptosis inducing agents.
    Kamal A; Dastagiri D; Ramaiah MJ; Reddy JS; Bharathi EV; Srinivas C; Pushpavalli SN; Pal D; Pal-Bhadra M
    ChemMedChem; 2010 Nov; 5(11):1937-47. PubMed ID: 20836120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal complexes as inhibitors of the 26S proteasome in tumor cells.
    Verani CN
    J Inorg Biochem; 2012 Jan; 106(1):59-67. PubMed ID: 22112841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel tamoxifen derivative, ridaifen-F, is a nonpeptidic small-molecule proteasome inhibitor.
    Hasegawa M; Yasuda Y; Tanaka M; Nakata K; Umeda E; Wang Y; Watanabe C; Uetake S; Kunoh T; Shionyu M; Sasaki R; Shiina I; Mizukami T
    Eur J Med Chem; 2014 Jan; 71():290-305. PubMed ID: 24321833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
    Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN
    Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal functionalized thiourea-containing dipeptides as multidrug-resistance reversers that target 20S proteasome and cell proliferation.
    Qin JM; Huang RZ; Yao GY; Liao ZX; Pan YM; Wang HS
    Eur J Med Chem; 2017 Jan; 126():259-269. PubMed ID: 27889629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.